Developer docs
API playgroundTry for free, no card

Search company profiles

InsightRX

Full company profile

uuid0000cha

Namestring
InsightRX
Legal namestring
Insight Rx, Inc.
Websiteurl
insight-rx.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

InsightRX is a San Francisco-based precision medicine company founded in 2015 by three pharmacometricians to bring model-informed precision dosing (MIPD) into clinical practice. The company operates an AI-powered platform combining Bayesian pharmacokinetic models, population-level analytics, and machine learning to optimize drug dosing at the point of care and in clinical trials. Its core products include InsightRX Nova, a bedside clinical decision support application for Bayesian dosing; InsightRX Apollo, a real-time clinical analytics platform with a natural-language interface (Apollo Studio); InsightRX Gemini, an automated vancomycin PK model selection algorithm; and Astra, a conversational PK/PD analysis tool for life sciences. A patented Continuous Learning process retrains dosing models using real-world institutional data, creating a data flywheel across 1,000+ hospital deployments and 5.6M+ personalized doses.

The company serves two primary customer segments: healthcare providers (hospital systems and clinical pharmacy teams) requiring precision dosing for therapeutic drug monitoring and antimicrobial stewardship, and life sciences organizations (biopharma and CROs) seeking dose optimization for clinical trials and regulatory submissions including FDA Project Optimus compliance. Go-to-market is sales-led and enterprise-oriented, with direct field sales targeting large hospital systems, multi-year subscription contracts priced based on hospital size and modules deployed, and pharmacist-led implementation and training services. Revenue is generated through annual subscriptions for the platform plus professional services for onboarding. Geographic reach spans the United States and the European Union (via CE Mark certification received in 2020). Customer evidence includes deployments at CHRISTUS Health, Memorial Sloan Kettering, OSF HealthCare, EvergreenHealth, and Cape Cod Healthcare, with documented outcomes such as 70% reduction in AKI events at CHRISTUS and a 96.1 KLAS customer satisfaction rating.

The company is venture-backed and private, having raised approximately $12.8M in equity (seed in 2017, $10M Series A in 2019) plus growth debt from CIBC Innovation Banking in February 2024. It operates with 11-50 employees and maintains an open-source portfolio of R packages (clinPK, PKPDsim, PKPDmap, MIPDtrial, MIPDeval, PKPDposterior) supporting the clinical pharmacology research community.

Short descriptiontext

InsightRX is a precision medicine company offering an AI-powered Bayesian dosing platform for hospitals and life sciences organizations, serving 1,000+ healthcare facilities with model-informed precision dosing, real-time analytics, and a patented continuous learning system.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
precision medicine software, model-informed dosing, pharmacokinetic analytics, clinical decision support, Bayesian dosing
Industry4 codes
PRIMARYHLAAANAE
Clinical Decision Support & Workflow Integration (EHR/oncology systems)
SECONDARYHLACAKAL
Medication Analytics, Outcomes & Cost Optimization
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAAAIAE
AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
NAICS code1 code
  • Software Publishers5132
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Precision Medicine Software
Social media profiles3 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Software Platform Subscription
TypeSubscription Recurring
Description

Annual or multi-year subscription licensing for access to InsightRX Nova, Apollo, and related platform capabilities. Pricing based on hospital size, number of beds, or clinician count. Includes software updates, technical support, and access to drug modules.

insight-rx.com
2Implementation and Training Services
TypeProfessional Services
Description

Pharmacist-led training, onboarding, and education services to help healthcare organizations implement and optimize use of the platform.

insight-rx.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Personnel, Technology or R&D, Marketing or Sales
Pricing details1 tier
1Enterprise pricing - Quote-based for large hospital systems
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based / Not publicly disclosed. Pricing varies by hospital size, number of beds, and product modules.

insight-rx.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 7 records shown
1Nova
Description

Bayesian dosing (MIPD) app for bedside clinical decision support

insight-rx.com
+6 more records
Core offering1 text field

InsightRX sells an AI-powered precision medicine software platform that uses Bayesian model-informed precision dosing (MIPD), pharmacokinetic models, real-world data, and machine learning to individualize drug dosing at the point of care for hospitals and in clinical trials for life sciences companies. The platform combines bedside clinical decision support (Nova), real-time population analytics (Apollo), natural-language analytics (Apollo Studio), automated model selection (Gemini), and conversational PK/PD workflow automation (Astra), supported by deep EHR integration and a patented Continuous Learning process.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 9 values shown
  • 70% reduction in AKI events, saving $8.1M annually (CHRISTUS Health)
+8 more records
Product overview1 text field

InsightRX offers a comprehensive AI-powered precision medicine platform combining Bayesian model-informed precision dosing (MIPD) with real-time clinical analytics. The core platform consists of InsightRX Nova (bedside clinical decision support for Bayesian dosing) and InsightRX Apollo (real-time pharmacy analytics), supported by Drug Modules for medication coverage and Continuous Learning for model optimization. For life sciences, the company provides Nova for Life Sciences and Apollo for Life Sciences for clinical trial applications, along with Companion Applications. The platform is enhanced by Apollo Studio (natural language analytics), Gemini (automated model selection), and Astra (conversational PK/PD analysis). The company also maintains a suite of open-source R packages (clinPK, PKPDsim, PKPDmap, MIPDtrial, MIPDeval, PKPDposterior) for the clinical pharmacology research community.

Product and service9 records
1InsightRX Nova
CategoryClinical Decision Support Software
Description

Bayesian dosing (MIPD) application for bedside clinical decision support, enabling pharmacists to individualize drug dosing using patient-specific data and validated population pharmacokinetic models.

2InsightRX Apollo
CategoryPharmacy Analytics Software
Description

Real-time clinical analytics platform providing population-level reporting, medication use evaluations, and performance tracking for pharmacy program directors.

3InsightRX Gemini
CategoryClinical Decision Support Software
Description

Automated vancomycin PK model selection algorithm built on more than 300,000 treatment courses, helping pharmacists select the most appropriate pharmacokinetic model for individual patients.

4Apollo Studio
CategoryPharmacy Analytics Software
Description

Natural language analytics interface within the Apollo platform that enables pharmacy teams to generate real-time clinical analyses and visualizations from institutional data by describing analyses in plain language.

5Astra
CategoryLife Sciences Analytics Software
Description

Conversational PK/PD analysis and end-to-end workflow automation tool for life sciences researchers, scientists, and pharmacometricians.

6MIPD for Life Sciences
CategoryLife Sciences Analytics Software
Description

MIPD solution for biopharma and clinical trial use, incorporating precision dosing into clinical trials to identify optimal dosing strategies.

7Nova for Life Sciences
CategoryLife Sciences Analytics Software
Description

Precision dosing application for clinical trial use, enabling individualized dosing in research and drug development settings.

8Apollo for Life Sciences
CategoryLife Sciences Analytics Software
Description

Advanced PKPD analytics platform for clinical trials, supporting pharmacometric analysis during drug development.

9Companion Applications
CategoryLife Sciences Analytics Software
Description

Tailored applications used alongside specific medications in life sciences and clinical trial settings.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Tabula Rasa HealthCare offers medication risk mitigation and pharmacy services including precision dosing tools for at-risk populations. It is a broader incumbent in medication optimization, overlapping with InsightRX on dose individualization but serving PACE/senior care as well as hospital pharmacy.

2Oracle Health (Cerner)
TypeBroad incumbent
Description

Oracle Health (formerly Cerner) is a leading hospital EHR whose PowerChart and pharmacy modules include clinical decision support and dosing tools. Comparable as both an integration partner for InsightRX and an incumbent competitor for pharmacy IT spend in large health systems.

TypeBroad incumbent
Description

FDB is a major drug knowledge and clinical decision support vendor whose MedKnowledge and order-entry screening products are embedded in EHRs nationwide. It is comparable as a medication analytics and decision support incumbent that competes for clinical pharmacy IT budget alongside InsightRX Apollo/Nova.

TypeBroad incumbent
Description

Epic is the dominant hospital EHR and embeds clinical decision support, dosing calculators, and Best Care Advisories within its workflow. Comparable as the underlying platform InsightRX integrates with and a potential long-term competitive threat if Epic extends in-house precision dosing capability.

5Mendel.ai
TypeEmerging player
Description

Mendel builds AI clinical reasoning and patient-matching tools for life sciences and provider organizations. Comparable as an emerging AI/clinical-informatics player overlapping with InsightRX's biopharma Astra product for clinical development decision support.

TypeBroad incumbent
Description

Wolters Kluwer offers Sentri7 pharmacy surveillance and Medi-Span drug data, widely deployed in hospital systems for medication analytics and antimicrobial stewardship. Comparable as a broader incumbent selling into the same pharmacy director and antimicrobial stewardship buyers that InsightRX targets.

TypeEmerging player
Description

AiCure applies AI to medication adherence and clinical trial patient monitoring. Comparable as an adjacent AI-driven medication outcomes player that intersects with InsightRX's clinical-trial dosing and adherence themes but focuses on visual adherence rather than pharmacokinetic modeling.

8Tempus Labs
TypeEmerging player
Description

Tempus is a precision medicine company building AI-driven clinical and molecular data products for oncology and other specialties. Comparable as an adjacent emerging player in precision medicine/AI that intersects with InsightRX's life sciences Astra product for clinical trial dose optimization.

TypeDirect peer
Description

DoseMeRx is a Bayesian model-informed precision dosing (MIPD) platform used by hospitals to individualize drug dosing. It is the closest direct competitor to InsightRX Nova in the bedside Bayesian dosing category, targeting the same pharmacy and antimicrobial stewardship buyers with comparable clinical decision support workflows.

TypeDirect peer
Description

PrecisePK provides pharmacokinetic dosing software for hospitals and clinics to optimize drug levels for antibiotics, anticoagulants, and other therapeutic areas. It competes head-on with InsightRX Nova in the AUC-guided vancomycin and aminoglycoside dosing space used by hospital pharmacy teams.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors13 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

InsightRX

Precision Medicine Softwareinsight-rx.com

InsightRX is a precision medicine company offering an AI-powered Bayesian dosing platform for hospitals and life sciences organizations, serving 1,000+ healthcare facilities with model-informed precision dosing, real-time analytics, and a patented continuous learning system.

What InsightRX does

InsightRX is a San Francisco-based precision medicine company founded in 2015 by three pharmacometricians to bring model-informed precision dosing (MIPD) into clinical practice. The company operates an AI-powered platform combining Bayesian pharmacokinetic models, population-level analytics, and machine learning to optimize drug dosing at the point of care and in clinical trials. Its core products include InsightRX Nova, a bedside clinical decision support application for Bayesian dosing; InsightRX Apollo, a real-time clinical analytics platform with a natural-language interface (Apollo Studio); InsightRX Gemini, an automated vancomycin PK model selection algorithm; and Astra, a conversational PK/PD analysis tool for life sciences. A patented Continuous Learning process retrains dosing models using real-world institutional data, creating a data flywheel across 1,000+ hospital deployments and 5.6M+ personalized doses.

The company serves two primary customer segments: healthcare providers (hospital systems and clinical pharmacy teams) requiring precision dosing for therapeutic drug monitoring and antimicrobial stewardship, and life sciences organizations (biopharma and CROs) seeking dose optimization for clinical trials and regulatory submissions including FDA Project Optimus compliance. Go-to-market is sales-led and enterprise-oriented, with direct field sales targeting large hospital systems, multi-year subscription contracts priced based on hospital size and modules deployed, and pharmacist-led implementation and training services. Revenue is generated through annual subscriptions for the platform plus professional services for onboarding. Geographic reach spans the United States and the European Union (via CE Mark certification received in 2020). Customer evidence includes deployments at CHRISTUS Health, Memorial Sloan Kettering, OSF HealthCare, EvergreenHealth, and Cape Cod Healthcare, with documented outcomes such as 70% reduction in AKI events at CHRISTUS and a 96.1 KLAS customer satisfaction rating.

The company is venture-backed and private, having raised approximately $12.8M in equity (seed in 2017, $10M Series A in 2019) plus growth debt from CIBC Innovation Banking in February 2024. It operates with 11-50 employees and maintains an open-source portfolio of R packages (clinPK, PKPDsim, PKPDmap, MIPDtrial, MIPDeval, PKPDposterior) supporting the clinical pharmacology research community.

InsightRX firmographics

Firmographics
Name
InsightRX
Legal name
Insight Rx, Inc.
Website
https://insight-rx.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
InsightRX is a precision medicine company offering an AI-powered Bayesian dosing platform for hospitals and life sciences organizations, serving 1,000+ healthcare facilities with model-informed precision dosing, real-time analytics, and a patented continuous learning system.
Ownership category
akta.pro rank

InsightRX industry classification

Industry
Product category
Precision Medicine Software
NAICS
Software Publishers (5132)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAAANAE
Clinical Decision Support & Workflow Integration (EHR/oncology systems)
SECONDARYHLACAKAL
Medication Analytics, Outcomes & Cost Optimization
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAAAIAE
AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)

Keywords

  • Precision medicine software
  • Model-informed dosing
  • Pharmacokinetic analytics
  • Clinical decision support
  • Bayesian dosing

Where InsightRX is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices1 record

Markets served

InsightRX business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. Software Platform Subscription: Annual or multi-year subscription licensing for access to InsightRX Nova, Apollo, and related platform capabilities. Pricing based on hospital size, number of beds, or clinician count. Includes software updates, technical support, and access to drug modules.
  2. Implementation and Training Services: Pharmacist-led training, onboarding, and education services to help healthcare organizations implement and optimize use of the platform.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise pricing - Quote-based for large hospital systems

Go-to-market motion2 records

Distribution channels3 records

Marketing channels9 records

InsightRX product offering

Product offering

Core offering

InsightRX sells an AI-powered precision medicine software platform that uses Bayesian model-informed precision dosing (MIPD), pharmacokinetic models, real-world data, and machine learning to individualize drug dosing at the point of care for hospitals and in clinical trials for life sciences companies. The platform combines bedside clinical decision support (Nova), real-time population analytics (Apollo), natural-language analytics (Apollo Studio), automated model selection (Gemini), and conversational PK/PD workflow automation (Astra), supported by deep EHR integration and a patented Continuous Learning process.

Product overview

InsightRX offers a comprehensive AI-powered precision medicine platform combining Bayesian model-informed precision dosing (MIPD) with real-time clinical analytics. The core platform consists of InsightRX Nova (bedside clinical decision support for Bayesian dosing) and InsightRX Apollo (real-time pharmacy analytics), supported by Drug Modules for medication coverage and Continuous Learning for model optimization. For life sciences, the company provides Nova for Life Sciences and Apollo for Life Sciences for clinical trial applications, along with Companion Applications. The platform is enhanced by Apollo Studio (natural language analytics), Gemini (automated model selection), and Astra (conversational PK/PD analysis). The company also maintains a suite of open-source R packages (clinPK, PKPDsim, PKPDmap, MIPDtrial, MIPDeval, PKPDposterior) for the clinical pharmacology research community.

Differentiator

Problem solved

Functional benefit

Brands

  • Nova: Bayesian dosing (MIPD) app for bedside clinical decision support
  • Apollo
  • Apollo Studio
  • Gemini
  • Astra
  • Apollo Gold
  • Continuous Learning

Products and services

  • InsightRX Nova Bayesian dosing (MIPD) application for bedside clinical decision support, enabling pharmacists to individualize drug dosing using patient-specific data and validated population pharmacokinetic models.
  • InsightRX Apollo Real-time clinical analytics platform providing population-level reporting, medication use evaluations, and performance tracking for pharmacy program directors.
  • InsightRX Gemini Automated vancomycin PK model selection algorithm built on more than 300,000 treatment courses, helping pharmacists select the most appropriate pharmacokinetic model for individual patients.
  • Apollo Studio Natural language analytics interface within the Apollo platform that enables pharmacy teams to generate real-time clinical analyses and visualizations from institutional data by describing analyses in plain language.
  • Astra Conversational PK/PD analysis and end-to-end workflow automation tool for life sciences researchers, scientists, and pharmacometricians.
  • MIPD for Life Sciences MIPD solution for biopharma and clinical trial use, incorporating precision dosing into clinical trials to identify optimal dosing strategies.
  • Nova for Life Sciences Precision dosing application for clinical trial use, enabling individualized dosing in research and drug development settings.
  • Apollo for Life Sciences Advanced PKPD analytics platform for clinical trials, supporting pharmacometric analysis during drug development.
  • Companion Applications Tailored applications used alongside specific medications in life sciences and clinical trial settings.

Quantifiable outcome

  • 70% reduction in AKI events, saving $8.1M annually (CHRISTUS Health)
  • +8 more outcomes

Companies that use InsightRX

Customer profile

Named customers10 records

Segments2 records

Ideal customer profiles2 records

InsightRX technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability4 records

Feature8 records

InsightRX partnerships and signals

Strategic signal

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

InsightRX competitors and assessment

Company assessment

Broad incumbents

  • Tabula Rasa HealthCare (CareVention): Tabula Rasa HealthCare offers medication risk mitigation and pharmacy services including precision dosing tools for at-risk populations. It is a broader incumbent in medication optimization, overlapping with InsightRX on dose individualization but serving PACE/senior care as well as hospital pharmacy.
  • Oracle Health (Cerner): Oracle Health (formerly Cerner) is a leading hospital EHR whose PowerChart and pharmacy modules include clinical decision support and dosing tools. Comparable as both an integration partner for InsightRX and an incumbent competitor for pharmacy IT spend in large health systems.
  • First Databank (FDB): FDB is a major drug knowledge and clinical decision support vendor whose MedKnowledge and order-entry screening products are embedded in EHRs nationwide. It is comparable as a medication analytics and decision support incumbent that competes for clinical pharmacy IT budget alongside InsightRX Apollo/Nova.
  • Epic Systems: Epic is the dominant hospital EHR and embeds clinical decision support, dosing calculators, and Best Care Advisories within its workflow. Comparable as the underlying platform InsightRX integrates with and a potential long-term competitive threat if Epic extends in-house precision dosing capability.
  • Wolters Kluwer Clinical Drug Information (Sentri7, Medi-Span): Wolters Kluwer offers Sentri7 pharmacy surveillance and Medi-Span drug data, widely deployed in hospital systems for medication analytics and antimicrobial stewardship. Comparable as a broader incumbent selling into the same pharmacy director and antimicrobial stewardship buyers that InsightRX targets.

Emerging players

  • Mendel.ai: Mendel builds AI clinical reasoning and patient-matching tools for life sciences and provider organizations. Comparable as an emerging AI/clinical-informatics player overlapping with InsightRX's biopharma Astra product for clinical development decision support.
  • AiCure: AiCure applies AI to medication adherence and clinical trial patient monitoring. Comparable as an adjacent AI-driven medication outcomes player that intersects with InsightRX's clinical-trial dosing and adherence themes but focuses on visual adherence rather than pharmacokinetic modeling.
  • Tempus Labs: Tempus is a precision medicine company building AI-driven clinical and molecular data products for oncology and other specialties. Comparable as an adjacent emerging player in precision medicine/AI that intersects with InsightRX's life sciences Astra product for clinical trial dose optimization.

Direct peers

  • DoseMeRx (Iguana Solutions): DoseMeRx is a Bayesian model-informed precision dosing (MIPD) platform used by hospitals to individualize drug dosing. It is the closest direct competitor to InsightRX Nova in the bedside Bayesian dosing category, targeting the same pharmacy and antimicrobial stewardship buyers with comparable clinical decision support workflows.
  • PrecisePK: PrecisePK provides pharmacokinetic dosing software for hospitals and clinics to optimize drug levels for antibiotics, anticoagulants, and other therapeutic areas. It competes head-on with InsightRX Nova in the AUC-guided vancomycin and aminoglycoside dosing space used by hospital pharmacy teams.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

InsightRX social profiles

Digital presence

InsightRX compliance and trust

Trust signal

Compliance1 record

InsightRX financial estimates

Financial estimate

Revenue estimate

Valuation estimate

InsightRX leadership team

Management profile

Number of profiles

Profiles7 records

InsightRX funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors13 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

InsightRX M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about InsightRX

What does InsightRX do?

InsightRX sells an AI-powered precision medicine software platform that uses Bayesian model-informed precision dosing (MIPD), pharmacokinetic models, real-world data, and machine learning to individualize drug dosing at the point of care for hospitals and in clinical trials for life sciences companies. The platform combines bedside clinical decision support (Nova), real-time population analytics (Apollo), natural-language analytics (Apollo Studio), automated model selection (Gemini), and conversational PK/PD workflow automation (Astra), supported by deep EHR integration and a patented Continuous Learning process.

Is InsightRX a public or private company?

InsightRX is a private company. It is classified as venture growth investor backed and is currently operating.

When was InsightRX founded?

InsightRX was founded in 2015. It employs 11 to 50 people.

Where is InsightRX based?

InsightRX is headquartered in San Francisco, United States, in the North America region.

How does InsightRX make money?

Two revenue lines are on record. Software Platform Subscription is the primary driver. The others are implementation and Training Services.

Who are InsightRX's main competitors?

Broad incumbents on record are Tabula Rasa HealthCare (CareVention), Oracle Health (Cerner), First Databank (FDB), Epic Systems and Wolters Kluwer Clinical Drug Information (Sentri7, Medi-Span). Emerging players are Mendel.ai, AiCure and Tempus Labs. Direct peers are DoseMeRx (Iguana Solutions) and PrecisePK.

Does InsightRX have an API?

No public API is recorded for InsightRX.

What industry is InsightRX in?

InsightRX's product category is Precision Medicine Software. Its primary akta.pro industry code is HLAAANAE, Clinical Decision Support & Workflow Integration (EHR/oncology systems), with a secondary code of HLACAKAL, Medication Analytics, Outcomes & Cost Optimization. Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Ani NewsHealthcare Veteran Manas Tripathi Launches InsightRx to Solve India's Healthcare Data DeficitHealthcare veteran Manas Tripathi has launched InsightRx, a specialized market research and strategy consulting firm aimed at addressing India's healthcare data deficit. The company plans to provide granular, ground-level insights to hospitals, diagnostic chains, and medtech firms to support strategic decision-making in the Indian market.AijournINSIGHTRX INTRODUCES APOLLO STUDIO: A CLINICAL INTELLIGENCE SYSTEM FOR PHARMACY ANALYTICSInsightRX announced the launch of Apollo Studio, a natural language analytics interface within its Apollo clinical intelligence platform that enables pharmacy teams to generate real-time clinical analyses and visualizations from their own institutional data without relying on static dashboards or manual data requests. The platform, which builds on deployments at Cape Cod Healthcare and CHRISTUS Health, allows users to describe analyses in plain language, filter by drug or patient population, and instantly generate corresponding visualizations for medication use evaluations and performance tracking. InsightRX's platform is currently used by over 40,000 clinicians across more than 1,000 hospitals, supporting over 5.5 million individualized dosing decisions across critical therapeutic areas.PR NewswireINSIGHTRX INTRODUCES APOLLO STUDIO: A CLINICAL INTELLIGENCE SYSTEM FOR PHARMACY ANALYTICSInsightRX has launched Apollo Studio, a natural language analytics interface within its Apollo clinical intelligence platform that enables pharmacy teams to generate real-time clinical analyses and visualizations directly from institutional data, replacing static dashboards and delayed reporting workflows.PR NewswireInsightRX Surpasses 1,000 Hospital Deployments as the Most Widely Used AI Precision Dosing SoftwareInsightRX announced that its AI precision dosing software has been deployed in over 1,000 hospitals, marking a significant expansion of its clinical decision support platform. The company stated that this milestone validates its thesis on precision dosing as a key entry point for AI in pharmacy and highlights the technology's evolution from infectious disease stewardship to broader acute care applications.PR NewswireInsightRX Achieves 96.1 Performance Score in KLAS Spotlight as the First Precision Dosing AI SolutionInsightRX received a 96.1 overall performance score in KLAS's inaugural Spotlight report for precision dosing AI solutions, significantly exceeding the Best in KLAS average of 80.6%, based on independent customer surveys. Customers reported measurable clinical outcomes including decreased medication side effects, higher therapeutic target attainment, and reductions in acute kidney injury within six months of adoption. The company is now developing a next-generation agentic AI clinical decision support platform that will integrate PK/PD modeling with pharmacogenomics and institutional protocols to expand beyond current therapeutic areas.PR NewswireInsightRX to Present Abstracts On Vancomycin Pharmacokinetic Model Performance, MIPD Protocols at ACoP15 ConferenceInsightRX announced it will present two research abstracts at the ACoP15 2024 conference in Phoenix, Arizona on November 10-13. The first abstract compares cystatin C and serum creatinine as renal function markers in vancomycin pharmacokinetic modeling, while the second introduces an open-source R package for simulating model-informed precision dosing trials. The company stated the research demonstrates how Bayesian model-informed precision dosing can improve antibiotic dosing accuracy, clinical outcomes, and operational efficiency.PharmiWeb.comInsightRX Announces the release of InsightRX GEMINI(SM)InsightRX announced the release of InsightRX GEMINI, a vancomycin dosing algorithm that automates PK model selection. The algorithm, built from 384,000+ patient courses, increased model prediction accuracy by up to 47% in external validation. It will be showcased at ASHP Midyear in New Orleans.PR NewswireInsightRX Announces the release of InsightRX GEMINI(SM)InsightRX, a healthcare technology company specializing in Bayesian model-informed precision dosing software, announced the release of InsightRX GEMINI, an enhanced dose-selection algorithm for vancomycin, on July 30, 2024. The algorithm, developed using datasets of over 384,000 patient treatment courses, automates pharmacokinetic model selection at the start of therapy and demonstrated up to 47% improvement in model prediction accuracy during external validation on 144,000 patients. The company states this one-click solution addresses a time-consuming manual process, enabling faster dosing decisions at point of care while reducing bias through best-practice standardization across healthcare systems.PR NewswireInsightRX Continues Momentum in Precision Dosing with Client Growth, New Scientific BreakthroughsInsightRX, a precision medicine company providing cloud-based clinical decision support software, announced continued momentum in 2024 with partnerships spanning 780 hospitals across 150 health systems and over 4 million personalized dose recommendations delivered. The company achieved several scientific breakthroughs including a new AI-powered feature called FitAssist that demonstrates up to 74% improvement in prediction accuracy for model-informed precision dosing, along with new vancomycin dosing models for both standard and obese patient populations. InsightRX is also expanding into the Life Sciences sector, having completed its first industry-sponsored clinical trial using precision dosing in partnership with a Top 25 life sciences company focused on pediatric labeling.TmcnetInsightRX Unveils Apollo Gold, a Powerful New Tier of the Apollo Analytics PlatformInsightRX announced the immediate availability of Apollo Gold, a premium tier of its Apollo analytics platform, providing clinical performance insights. The company cited antibiotic stewardship as a key use case, noting AKIs impact nearly half a million U.S. patients annually, costing $4.7–$24 billion in healthcare costs.